Get the latest Science News and Discoveries
Next-generation KRAS G12C inhibitor elisrasib elicited promising response rates in patients with advanced lung cancer - EurekAlert!
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.
None
Or read this on Eureka Alert